[Neurogenic or idiopathic destrusor overactivity after failed antimuscarinic treatment : clinical value of external temporary electrostimulation]
- PMID: 20057991
- DOI: 10.1007/s00120-009-2179-x
[Neurogenic or idiopathic destrusor overactivity after failed antimuscarinic treatment : clinical value of external temporary electrostimulation]
Abstract
Antimuscarinic drugs are regarded as the standard treatment of detrusor overactivity (DO). However, side effects and lack of efficacy cause patients to discontinue long-term therapy. We evaluated the clinical efficacy of functional external electrostimulation (FES) as "second-line" therapy in patients with symptomatic idiopathic or neurogenic DO.In a retrospective study, 52 patients (38 women and 14 men) were evaluated at least 1 year after FES. Eighteen patients (32.7%) regarded FES as successful. No change occurred in 34 patients (65.4%) and 1 patient reported worsening of symptoms. Treatment success lasted for 13.2 months. In successfully treated patients, voiding frequency was significantly reduced from 13.3/24 h to 6.1/24 h under FES and to 6.75/24 h at follow-up. FES is a clinically useful, well-tolerated, conservative second-line treatment option after failed antimuscarinic treatment in patients with idiopathic or neurogenic DO.
Similar articles
-
Prospective randomized comparison of oxybutynin, functional electrostimulation, and pelvic floor training for treatment of detrusor overactivity in women.Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1055-61. doi: 10.1007/s00192-008-0586-y. Epub 2008 Mar 11. Int Urogynecol J Pelvic Floor Dysfunct. 2008. PMID: 18330483 Clinical Trial.
-
Actual treatment of overactive bladder and urge urinary incontinence.Minerva Urol Nefrol. 2013 Mar;65(1):21-35. Minerva Urol Nefrol. 2013. PMID: 23538308 Review.
-
Effect of pelvic floor interferential electrostimulation on urodynamic parameters and incontinency of children with myelomeningocele and detrusor overactivity.Urology. 2009 Aug;74(2):324-9. doi: 10.1016/j.urology.2008.12.085. Epub 2009 May 24. Urology. 2009. PMID: 19476983 Clinical Trial.
-
Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin.BMC Urol. 2017 Apr 13;17(1):30. doi: 10.1186/s12894-017-0216-4. BMC Urol. 2017. PMID: 28403849 Free PMC article.
-
Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity.Int J Gynaecol Obstet. 2006 Dec;95(3):305-11. doi: 10.1016/j.ijgo.2006.08.014. Epub 2006 Oct 27. Int J Gynaecol Obstet. 2006. PMID: 17070528 Review.
Cited by
-
Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1.Urology. 2016 Mar;89:33-8. doi: 10.1016/j.urology.2015.09.036. Epub 2015 Dec 24. Urology. 2016. PMID: 26724409 Free PMC article. Clinical Trial.
-
[Overactive bladder-which treatment when?].Urologe A. 2017 Dec;56(12):1532-1538. doi: 10.1007/s00120-017-0522-1. Urologe A. 2017. PMID: 29043374 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous